Lund, Sweden, 15.00 CET, 14 April 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that new preclinical data1 has been published that further support BONESUPPORT’s ambition to develop a combination product of the company’s platform technology CERAMENT® and bisphosphonate, a pharmaceutical that counteracts osteoporosis. In a pre-clinical …